Assessing	O
sex	O
-	O
differences	O
and	O
the	O
effect	O
of	O
timing	O
of	O
vaccination	B:C0042196
on	O
immunogenicity	O
,	O
reactogenicity	O
and	O
efficacy	O
of	O
vaccines	O
in	O
young	O
children	O
:	O
study	O
protocol	I:C2348563
for	O
an	O
individual	O
participant	O
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
Disease	O
incidence	O
differs	O
between	O
males	O
and	O
females	O
for	O
some	O
infectious	O
or	O
inflammatory	O
diseases	I:C1290884
.	O

Assessing	O
sex	O
-	O
differences	O
and	O
the	O
effect	O
of	O
timing	O
of	O
vaccination	O
on	O
immunogenicity	B:C4277607
,	O
reactogenicity	O
and	O
efficacy	O
of	O
vaccines	O
in	O
young	O
children	O
:	O
study	O
protocol	I:C2348563
for	O
an	O
individual	O
participant	O
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
Disease	O
incidence	O
differs	O
between	O
males	O
and	O
females	O
for	O
some	O
infectious	O
or	O
inflammatory	O
diseases	I:C1290884
.	O

Assessing	O
sex	O
-	O
differences	O
and	O
the	O
effect	O
of	O
timing	O
of	O
vaccination	O
on	O
immunogenicity	O
,	O
reactogenicity	B:C1691781
and	O
efficacy	O
of	O
vaccines	O
in	O
young	O
children	O
:	O
study	O
protocol	I:C2348563
for	O
an	O
individual	O
participant	O
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
Disease	O
incidence	O
differs	O
between	O
males	O
and	O
females	O
for	O
some	O
infectious	O
or	O
inflammatory	O
diseases	I:C1290884
.	O

Assessing	O
sex	O
-	O
differences	O
and	O
the	O
effect	O
of	O
timing	O
of	O
vaccination	O
on	O
immunogenicity	O
,	O
reactogenicity	O
and	O
efficacy	O
of	O
vaccines	O
in	O
young	O
children	O
:	O
study	B:C2348563
protocol	I:C2348563
for	O
an	O
individual	O
participant	O
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
Disease	O
incidence	O
differs	O
between	O
males	O
and	O
females	O
for	O
some	O
infectious	O
or	O
inflammatory	O
diseases	I:C1290884
.	O

Assessing	O
sex	O
-	O
differences	O
and	O
the	O
effect	O
of	O
timing	O
of	O
vaccination	O
on	O
immunogenicity	O
,	O
reactogenicity	O
and	O
efficacy	O
of	O
vaccines	O
in	O
young	O
children	O
:	O
study	O
protocol	I:C2348563
for	O
an	O
individual	B:C0237401
participant	O
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
Disease	O
incidence	O
differs	O
between	O
males	O
and	O
females	O
for	O
some	O
infectious	O
or	O
inflammatory	O
diseases	I:C1290884
.	O

Assessing	O
sex	O
-	O
differences	O
and	O
the	O
effect	O
of	O
timing	O
of	O
vaccination	O
on	O
immunogenicity	O
,	O
reactogenicity	O
and	O
efficacy	O
of	O
vaccines	O
in	O
young	O
children	O
:	O
study	O
protocol	I:C2348563
for	O
an	O
individual	O
participant	B:C0679646
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
Disease	O
incidence	O
differs	O
between	O
males	O
and	O
females	O
for	O
some	O
infectious	O
or	O
inflammatory	O
diseases	I:C1290884
.	O

Assessing	O
sex	O
-	O
differences	O
and	O
the	O
effect	O
of	O
timing	O
of	O
vaccination	O
on	O
immunogenicity	O
,	O
reactogenicity	O
and	O
efficacy	O
of	O
vaccines	O
in	O
young	O
children	O
:	O
study	O
protocol	I:C2348563
for	O
an	O
individual	O
participant	O
data	O
meta-	B:C0920317
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
Disease	O
incidence	O
differs	O
between	O
males	O
and	O
females	O
for	O
some	O
infectious	O
or	O
inflammatory	O
diseases	I:C1290884
.	O

Assessing	O
sex	O
-	O
differences	O
and	O
the	O
effect	O
of	O
timing	O
of	O
vaccination	O
on	O
immunogenicity	O
,	O
reactogenicity	O
and	O
efficacy	O
of	O
vaccines	O
in	O
young	O
children	O
:	O
study	O
protocol	I:C2348563
for	O
an	O
individual	O
participant	O
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	B:C0206035
controlled	I:C0206035
trials	I:C0206035
Disease	O
incidence	O
differs	O
between	O
males	O
and	O
females	O
for	O
some	O
infectious	O
or	O
inflammatory	O
diseases	I:C1290884
.	O

Assessing	O
sex	O
-	O
differences	O
and	O
the	O
effect	O
of	O
timing	O
of	O
vaccination	O
on	O
immunogenicity	O
,	O
reactogenicity	O
and	O
efficacy	O
of	O
vaccines	O
in	O
young	O
children	O
:	O
study	O
protocol	I:C2348563
for	O
an	O
individual	O
participant	O
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
Disease	B:C0012634
incidence	O
differs	O
between	O
males	O
and	O
females	O
for	O
some	O
infectious	O
or	O
inflammatory	O
diseases	I:C1290884
.	O

Assessing	O
sex	O
-	O
differences	O
and	O
the	O
effect	O
of	O
timing	O
of	O
vaccination	O
on	O
immunogenicity	O
,	O
reactogenicity	O
and	O
efficacy	O
of	O
vaccines	O
in	O
young	O
children	O
:	O
study	O
protocol	I:C2348563
for	O
an	O
individual	O
participant	O
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
Disease	O
incidence	O
differs	O
between	O
males	O
and	O
females	O
for	O
some	O
infectious	B:C0009450
or	O
inflammatory	O
diseases	I:C1290884
.	O

Assessing	O
sex	O
-	O
differences	O
and	O
the	O
effect	O
of	O
timing	O
of	O
vaccination	O
on	O
immunogenicity	O
,	O
reactogenicity	O
and	O
efficacy	O
of	O
vaccines	O
in	O
young	O
children	O
:	O
study	O
protocol	I:C2348563
for	O
an	O
individual	O
participant	O
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
Disease	O
incidence	O
differs	O
between	O
males	O
and	O
females	O
for	O
some	O
infectious	O
or	O
inflammatory	B:C1290884
diseases	I:C1290884
.	O

Sex	O
-	O
differences	O
in	O
immune	B:C0301872
responses	I:C0301872
to	O
some	O
vaccines	O
have	O
also	O
been	O
observed	O
,	O
mostly	O
to	O
viral	O
vaccines	I:C0042742
in	O
adults	O
.	O

Sex	O
-	O
differences	O
in	O
immune	O
responses	I:C0301872
to	O
some	O
vaccines	B:C0042210
have	O
also	O
been	O
observed	O
,	O
mostly	O
to	O
viral	O
vaccines	I:C0042742
in	O
adults	O
.	O

Sex	O
-	O
differences	O
in	O
immune	O
responses	I:C0301872
to	O
some	O
vaccines	O
have	O
also	O
been	O
observed	O
,	O
mostly	O
to	O
viral	B:C0042742
vaccines	I:C0042742
in	O
adults	O
.	O

Little	O
evidence	O
is	O
available	O
on	O
whether	O
sex	O
-	O
differences	O
occur	O
in	O
response	B:C1704632
to	O
immunisation	O
in	O
infancy	O
even	O
though	O
this	O
is	O
the	O
age	O
group	O
in	O
which	O
most	O
vaccines	O
are	O
administered	O
.	O

Little	O
evidence	O
is	O
available	O
on	O
whether	O
sex	O
-	O
differences	O
occur	O
in	O
response	O
to	O
immunisation	B:C0020971
in	O
infancy	O
even	O
though	O
this	O
is	O
the	O
age	O
group	O
in	O
which	O
most	O
vaccines	O
are	O
administered	O
.	O

Little	O
evidence	O
is	O
available	O
on	O
whether	O
sex	O
-	O
differences	O
occur	O
in	O
response	O
to	O
immunisation	O
in	O
infancy	O
even	O
though	O
this	O
is	O
the	O
age	O
group	O
in	O
which	O
most	O
vaccines	B:C0042210
are	O
administered	O
.	O

Factors	O
other	O
than	O
sex	O
,	O
such	O
as	O
timing	O
or	O
coadministration	B:C1533734
of	O
other	O
vaccines	O
,	O
can	O
also	O
influence	O
the	O
immune	O
response	I:C0301872
to	O
vaccination	O
.	O

Factors	O
other	O
than	O
sex	O
,	O
such	O
as	O
timing	O
or	O
coadministration	O
of	O
other	O
vaccines	B:C0042210
,	O
can	O
also	O
influence	O
the	O
immune	O
response	I:C0301872
to	O
vaccination	O
.	O

Factors	O
other	O
than	O
sex	O
,	O
such	O
as	O
timing	O
or	O
coadministration	O
of	O
other	O
vaccines	O
,	O
can	O
also	O
influence	O
the	O
immune	B:C0301872
response	I:C0301872
to	O
vaccination	O
.	O

Factors	O
other	O
than	O
sex	O
,	O
such	O
as	O
timing	O
or	O
coadministration	O
of	O
other	O
vaccines	O
,	O
can	O
also	O
influence	O
the	O
immune	O
response	I:C0301872
to	O
vaccination	B:C0042196
.	O

Individual	B:C0237401
participant	O
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
vaccines	O
in	O
healthy	O
infants	O
and	O
young	O
children	O
will	O
be	O
conducted	O
.	O

Individual	O
participant	B:C0679646
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
vaccines	O
in	O
healthy	O
infants	O
and	O
young	O
children	O
will	O
be	O
conducted	O
.	O

Individual	O
participant	O
data	O
meta-	B:C0920317
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
vaccines	O
in	O
healthy	O
infants	O
and	O
young	O
children	O
will	O
be	O
conducted	O
.	O

Individual	O
participant	O
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	B:C0206035
controlled	I:C0206035
trials	I:C0206035
of	O
vaccines	O
in	O
healthy	O
infants	O
and	O
young	O
children	O
will	O
be	O
conducted	O
.	O

Individual	O
participant	O
data	O
meta-	O
analysis	I:C0920317
of	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
vaccines	B:C0042210
in	O
healthy	O
infants	O
and	O
young	O
children	O
will	O
be	O
conducted	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	B:C0206035
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	B:C0042210
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	B:C0012546
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	B:C0039614
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	B:C0006017
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	B:C0032371
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	B:C0121772
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	B:C0019163
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	B:C0038410
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	B:C0027575
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	B:C0025007
,	O
mumps	O
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	B:C0026780
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	B:C0035920
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	O
,	O
varicella	B:C0008049
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	B:C0035870
will	O
be	O
combined	O
for	O
analysis	O
.	O

Fully	O
anonymised	O
data	O
from	O
∼	O
170	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
of	O
v	O
accines	O
for	O
diphtheria	O
,	O
tetanus	O
,	O
Bordetella	O
pertussis	I:C0006017
,	O
polio	O
,	O
Haemophilus	O
influenzae	I:C0121772
type	I:C0121772
B	I:C0121772
,	O
hepatitis	O
B	I:C0019163
,	O
Streptococcus	O
pneumoniae	I:C0038410
,	O
Neisseria	O
meningitidis	I:C0027575
,	O
measles	O
,	O
mumps	O
,	O
rubella	O
,	O
varicella	O
and	O
rotavirus	O
will	O
be	O
combined	O
for	O
analysis	B:C0936012
.	O

Outcomes	O
include	O
measures	O
of	O
immunogenicity	B:C4277607
(	O
immunoglobulins	O
)	O
,	O
reactogenicity	O
,	O
safety	O
and	O
disease	O
-	O
specific	O
clinical	O
efficacy	O
.	O

Outcomes	O
include	O
measures	O
of	O
immunogenicity	O
(	O
immunoglobulins	B:C0021027
)	O
,	O
reactogenicity	O
,	O
safety	O
and	O
disease	O
-	O
specific	O
clinical	O
efficacy	O
.	O

Outcomes	O
include	O
measures	O
of	O
immunogenicity	O
(	O
immunoglobulins	O
)	O
,	O
reactogenicity	B:C1691781
,	O
safety	O
and	O
disease	O
-	O
specific	O
clinical	O
efficacy	O
.	O

Outcomes	O
include	O
measures	O
of	O
immunogenicity	O
(	O
immunoglobulins	O
)	O
,	O
reactogenicity	O
,	O
safety	O
and	O
disease	B:C0012634
-	O
specific	O
clinical	O
efficacy	O
.	O

Data	O
from	O
trials	B:C0008976
of	O
vaccines	O
containing	O
similar	O
components	O
will	O
be	O
combined	O
in	O
hierarchical	O
models	O
and	O
the	O
effect	O
of	O
sex	O
and	O
timing	O
of	O
vaccinations	O
estimated	O
for	O
each	O
outcome	O
separately	O
.	O

Data	O
from	O
trials	O
of	O
vaccines	B:C0042210
containing	O
similar	O
components	O
will	O
be	O
combined	O
in	O
hierarchical	O
models	O
and	O
the	O
effect	O
of	O
sex	O
and	O
timing	O
of	O
vaccinations	O
estimated	O
for	O
each	O
outcome	O
separately	O
.	O

Data	O
from	O
trials	O
of	O
vaccines	O
containing	O
similar	O
components	O
will	O
be	O
combined	O
in	O
hierarchical	O
models	B:C3161035
and	O
the	O
effect	O
of	O
sex	O
and	O
timing	O
of	O
vaccinations	O
estimated	O
for	O
each	O
outcome	O
separately	O
.	O

Data	O
from	O
trials	O
of	O
vaccines	O
containing	O
similar	O
components	O
will	O
be	O
combined	O
in	O
hierarchical	O
models	O
and	O
the	O
effect	O
of	O
sex	O
and	O
timing	O
of	O
vaccinations	B:C0042196
estimated	O
for	O
each	O
outcome	O
separately	O
.	O

Systematic	B:C1955832
reviews	I:C1955832
of	O
published	O
estimates	O
of	O
sex	O
-	O
differences	O
cannot	O
adequately	O
answer	O
questions	O
in	O
this	O
field	O
since	O
such	O
comparisons	O
are	O
never	O
the	O
main	O
purpose	O
of	O
a	O
clinical	O
trial	I:C0008976
,	O
thus	O
a	O
large	O
degree	O
of	O
reporting	O
bias	O
exists	O
in	O
the	O
published	O
literature	O
.	O

Systematic	O
reviews	I:C1955832
of	O
published	O
estimates	O
of	O
sex	O
-	O
differences	O
cannot	O
adequately	O
answer	O
questions	O
in	O
this	O
field	O
since	O
such	O
comparisons	O
are	O
never	O
the	O
main	O
purpose	O
of	O
a	O
clinical	B:C0008976
trial	I:C0008976
,	O
thus	O
a	O
large	O
degree	O
of	O
reporting	O
bias	O
exists	O
in	O
the	O
published	O
literature	O
.	O

Systematic	O
reviews	I:C1955832
of	O
published	O
estimates	O
of	O
sex	O
-	O
differences	O
cannot	O
adequately	O
answer	O
questions	O
in	O
this	O
field	O
since	O
such	O
comparisons	O
are	O
never	O
the	O
main	O
purpose	O
of	O
a	O
clinical	O
trial	I:C0008976
,	O
thus	O
a	O
large	O
degree	O
of	O
reporting	B:C0700287
bias	O
exists	O
in	O
the	O
published	O
literature	O
.	O

Systematic	O
reviews	I:C1955832
of	O
published	O
estimates	O
of	O
sex	O
-	O
differences	O
cannot	O
adequately	O
answer	O
questions	O
in	O
this	O
field	O
since	O
such	O
comparisons	O
are	O
never	O
the	O
main	O
purpose	O
of	O
a	O
clinical	O
trial	I:C0008976
,	O
thus	O
a	O
large	O
degree	O
of	O
reporting	O
bias	O
exists	O
in	O
the	O
published	O
literature	B:C0023866
.	O

Recent	O
improvements	O
in	O
the	O
widespread	B:C0205391
availability	O
of	O
individual	O
participant	O
data	O
from	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	O
individual	O
participant	O
data	O
meta-	O
analyses	I:C0920317
which	O
were	O
previously	O
impossible	O
,	O
thereby	O
reducing	O
the	O
effect	O
of	O
publication	O
or	O
reporting	O
bias	O
on	O
the	O
understanding	O
of	O
the	O
infant	O
immune	O
response	I:C0301872
.	O

Recent	O
improvements	O
in	O
the	O
widespread	O
availability	O
of	O
individual	B:C0237401
participant	O
data	O
from	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	O
individual	O
participant	O
data	O
meta-	O
analyses	I:C0920317
which	O
were	O
previously	O
impossible	O
,	O
thereby	O
reducing	O
the	O
effect	O
of	O
publication	O
or	O
reporting	O
bias	O
on	O
the	O
understanding	O
of	O
the	O
infant	O
immune	O
response	I:C0301872
.	O

Recent	O
improvements	O
in	O
the	O
widespread	O
availability	O
of	O
individual	O
participant	B:C0679646
data	O
from	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	O
individual	O
participant	O
data	O
meta-	O
analyses	I:C0920317
which	O
were	O
previously	O
impossible	O
,	O
thereby	O
reducing	O
the	O
effect	O
of	O
publication	O
or	O
reporting	O
bias	O
on	O
the	O
understanding	O
of	O
the	O
infant	O
immune	O
response	I:C0301872
.	O

Recent	O
improvements	O
in	O
the	O
widespread	O
availability	O
of	O
individual	O
participant	O
data	O
from	O
randomised	B:C0206035
controlled	I:C0206035
trials	I:C0206035
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	O
individual	O
participant	O
data	O
meta-	O
analyses	I:C0920317
which	O
were	O
previously	O
impossible	O
,	O
thereby	O
reducing	O
the	O
effect	O
of	O
publication	O
or	O
reporting	O
bias	O
on	O
the	O
understanding	O
of	O
the	O
infant	O
immune	O
response	I:C0301872
.	O

Recent	O
improvements	O
in	O
the	O
widespread	O
availability	O
of	O
individual	O
participant	O
data	O
from	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	O
individual	B:C0237401
participant	O
data	O
meta-	O
analyses	I:C0920317
which	O
were	O
previously	O
impossible	O
,	O
thereby	O
reducing	O
the	O
effect	O
of	O
publication	O
or	O
reporting	O
bias	O
on	O
the	O
understanding	O
of	O
the	O
infant	O
immune	O
response	I:C0301872
.	O

Recent	O
improvements	O
in	O
the	O
widespread	O
availability	O
of	O
individual	O
participant	O
data	O
from	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	O
individual	O
participant	B:C0679646
data	O
meta-	O
analyses	I:C0920317
which	O
were	O
previously	O
impossible	O
,	O
thereby	O
reducing	O
the	O
effect	O
of	O
publication	O
or	O
reporting	O
bias	O
on	O
the	O
understanding	O
of	O
the	O
infant	O
immune	O
response	I:C0301872
.	O

Recent	O
improvements	O
in	O
the	O
widespread	O
availability	O
of	O
individual	O
participant	O
data	O
from	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	O
individual	O
participant	O
data	O
meta-	B:C0920317
analyses	I:C0920317
which	O
were	O
previously	O
impossible	O
,	O
thereby	O
reducing	O
the	O
effect	O
of	O
publication	O
or	O
reporting	O
bias	O
on	O
the	O
understanding	O
of	O
the	O
infant	O
immune	O
response	I:C0301872
.	O

Recent	O
improvements	O
in	O
the	O
widespread	O
availability	O
of	O
individual	O
participant	O
data	O
from	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	O
individual	O
participant	O
data	O
meta-	O
analyses	I:C0920317
which	O
were	O
previously	O
impossible	B:C0243095
,	O
thereby	O
reducing	O
the	O
effect	O
of	O
publication	O
or	O
reporting	O
bias	O
on	O
the	O
understanding	O
of	O
the	O
infant	O
immune	O
response	I:C0301872
.	O

Recent	O
improvements	O
in	O
the	O
widespread	O
availability	O
of	O
individual	O
participant	O
data	O
from	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	O
individual	O
participant	O
data	O
meta-	O
analyses	I:C0920317
which	O
were	O
previously	O
impossible	O
,	O
thereby	O
reducing	O
the	O
effect	O
of	O
publication	B:C0034036
or	O
reporting	O
bias	O
on	O
the	O
understanding	O
of	O
the	O
infant	O
immune	O
response	I:C0301872
.	O

Recent	O
improvements	O
in	O
the	O
widespread	O
availability	O
of	O
individual	O
participant	O
data	O
from	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	O
individual	O
participant	O
data	O
meta-	O
analyses	I:C0920317
which	O
were	O
previously	O
impossible	O
,	O
thereby	O
reducing	O
the	O
effect	O
of	O
publication	O
or	O
reporting	B:C0700287
bias	O
on	O
the	O
understanding	O
of	O
the	O
infant	O
immune	O
response	I:C0301872
.	O

Recent	O
improvements	O
in	O
the	O
widespread	O
availability	O
of	O
individual	O
participant	O
data	O
from	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	O
individual	O
participant	O
data	O
meta-	O
analyses	I:C0920317
which	O
were	O
previously	O
impossible	O
,	O
thereby	O
reducing	O
the	O
effect	O
of	O
publication	O
or	O
reporting	O
bias	O
on	O
the	O
understanding	B:C0162340
of	O
the	O
infant	O
immune	O
response	I:C0301872
.	O

Recent	O
improvements	O
in	O
the	O
widespread	O
availability	O
of	O
individual	O
participant	O
data	O
from	O
randomised	O
controlled	I:C0206035
trials	I:C0206035
makes	O
it	O
feasible	O
to	O
conduct	O
extensive	O
individual	O
participant	O
data	O
meta-	O
analyses	I:C0920317
which	O
were	O
previously	O
impossible	O
,	O
thereby	O
reducing	O
the	O
effect	O
of	O
publication	O
or	O
reporting	O
bias	O
on	O
the	O
understanding	O
of	O
the	O
infant	O
immune	B:C0301872
response	I:C0301872
.	O

No	O
ethics	O
review	B:C0282443
is	O
required	O
for	O
secondary	O
analyses	O
of	O
anonymised	O
data	O
.	O

